Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
15.07
-0.77 (-4.86%)
At close: Jun 5, 2026, 4:00 PM EDT
15.50
+0.43 (2.85%)
After-hours: Jun 5, 2026, 7:36 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $17.25 million as of June 5, 2026. Its market cap has decreased by -56.77% in one year.
Market Cap
17.25M
Enterprise Value
15.21M
1-Year Change
-56.77%
Ranking
Category
Stock Price
$15.07
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $17.25M, a decrease of -94.08%. That is a compound annual growth rate of -23.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 17.25M | 30.36% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curis | 19.99M |
| AEON Biopharma | 19.40M |
| Passage Bio | 19.25M |
| Exicure | 18.87M |
| Tempest Therapeutics | 18.65M |
| Quince Therapeutics | 17.93M |
| Lipocine | 17.74M |
| GT Biopharma | 17.20M |